Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0XPNFT
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
CN106714844B ADC-104
|
|||||
| Synonyms |
ADC-104
Click to Show/Hide
|
|||||
| Organization |
Genentech Inc
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1.7
|
|||||
| Structure |
|
|||||
| Antibody Name |
10F4v3 HC A118C
|
Antibody Info | ||||
| Antigen Name |
B-cell receptor CD22 (CD22)
|
Antigen Info | ||||
| Payload Name |
PNU-159682
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 2-alpha (TOP2A)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
CN106714844B-ADC-104-linker-PNU-159682
|
|||||